The financial trend score for Max Healthcare has moved to 13 from -1 over the past three months, reflecting an adjustment in evaluation that highlights recent operational performance. The operating profit to net sales ratio for the quarter reached 26.93%, marking the highest level recorded by the company in recent periods. Earnings per share (EPS) for the quarter stood at ₹5.05, while profit after tax (PAT) was reported at ₹491.30 crore, both figures representing peak quarterly outcomes.
Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!
- Just announced pick
- Pre-market insights shared
- Tyres & Allied weekly focus
Despite these positive quarterly financial markers, certain parameters indicate areas of concern. Operating cash flow for the year is at its lowest level of ₹598.01 crore, while the debt-equity ratio at half-year stands at 0.33 times, the highest recorded for the company. Interest expenses for the nine-month period have shown a growth rate of 49.33%, reaching ₹163.98 crore. Additionally, cash and cash equivalents at half-year are at ₹497.02 crore, the lowest in recent history, and the debtors turnover ratio has declined to 8.47 times.
From a market perspective, Max Healthcare's stock price closed at ₹1,120.00, slightly below the previous close of ₹1,121.90. The stock's 52-week high is ₹1,314.30, with a low of ₹938.05. Intraday trading on the latest session ranged between ₹1,114.15 and ₹1,145.65. The stock's short-term return over one week was 2.24%, outperforming the Sensex's 0.96% return. However, over one month, the stock recorded a negative return of 6.85%, contrasting with the Sensex's positive 0.86%. Year-to-date, Max Healthcare's return is marginally negative at -0.67%, while the Sensex has gained 8.36%. Over longer horizons, the stock has delivered substantial returns, with a 3-year return of 162.39% compared to Sensex's 37.31%, and a 5-year return of 834.89% versus Sensex's 91.65%.
Considering Max Healthcare Institute ? Wait! SwitchER has found potentially better options in Hospital and beyond. Compare this large-cap with top-rated alternatives now!
- Better options discovered
- Hospital + beyond scope
- Top-rated alternatives ready
Max Healthcare Institute's recent quarterly performance highlights a complex financial landscape. While revenue and profitability metrics have reached new quarterly highs, cash flow and leverage indicators suggest caution. The adjustment in the financial trend parameter reflects these mixed signals, underscoring the importance of a balanced analysis for investors considering exposure to the hospital sector. The company's long-term stock returns remain robust relative to the broader market, though short-term fluctuations have been more volatile.
Investors should continue to monitor Max Healthcare's evolving financial parameters, particularly operating cash flow and debt levels, alongside its operational profitability. The hospital sector's dynamics and broader market conditions will also play a critical role in shaping the stock's trajectory in the coming quarters.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
